Actively Recruiting
HUC-MSC for Treatment of High-risk HPV Infection
Led by Shanghai East Hospital · Updated on 2024-09-24
60
Participants Needed
1
Research Sites
131 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the safety and initial effectiveness of human umbilical cord mesenchymal stem cells in HPV clearance.
CONDITIONS
Official Title
HUC-MSC for Treatment of High-risk HPV Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 25-60 with a sexual history of more than 2 years
- Confirmed high-risk HPV infection by HPV-24 test
- Diagnosed with persistent high-risk HPV infection
- Not participating in other clinical trials or using anti-HPV drugs recently
- Negative pregnancy test and agree to use effective contraception during and for 6 months after the study if fertile
- Voluntarily agree to participate and sign informed consent
You will not qualify if you...
- Preparing for pregnancy, pregnant, or breastfeeding
- Diagnosed with high-grade squamous intraepithelial lesion (HSIL) or cervical cancer
- Previously vaccinated against HPV
- History of severe drug allergies or allergies to stem cell products or biologics
- Previous cervical physical therapy or related surgery
- Severe immune dysfunction or serious diseases of cardiovascular, liver, kidney, nervous, hematopoietic systems, malignant tumors, or mental diseases
- Recent use of antiviral drugs, immunosuppressants, immunomodulators, or steroid hormones affecting the immune system
- Acute genital or pelvic inflammation
- Participation in other drug clinical trials within the past 3 months
- Other conditions deemed inappropriate by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Shanghai East Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, China, 200120
Actively Recruiting
Research Team
J
Jingjing Liu, M.D,.PH.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here